In the long run, compounds 86 and 87, which have been identified by exploration of ER degradation and antagonism in vitro accompanied by in vivo antagonism and culminating in oral publicity, could induce tumor regression in the tamoxifen-resistant breast cancer xenograft. Especially, compound 95 served as probably the most efficacious https://hemalchem.com/product-category/indazole-based/